DEXUS Crecimiento futuro

Future controles de criterios 4/6

Se prevé un crecimiento anual de los beneficios y los ingresos de DEXUS de 47.9% y 16.5% por año respectivamente. Se prevé que el BPA crezca en un 50.2% al año. Se espera que la rentabilidad financiera sea de 6.5% en 3 años.

Información clave

47.9%

Tasa de crecimiento de los beneficios

50.2%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Office REITs	50.9%
Tasa de crecimiento de los ingresos	16.5%
Rentabilidad financiera futura	6.5%
Cobertura de analistas	Good
Última actualización	19 Dec 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Shareholders May Not Be So Generous With Dexus' (ASX:DXS) CEO Compensation And Here's Why

Oct 12

Dexus (ASX:DXS) Has Compensated Shareholders With A Respectable 58% Return On Their Investment

Dec 24

What Kind Of Shareholders Own Dexus (ASX:DXS)?

Dec 03

Previsiones de crecimiento de beneficios e ingresos

ASX:DXS - Estimaciones futuras de los analistas y datos financieros pasados (AUD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
6/30/2027	875	748	88	648	2
6/30/2026	838	717	478	616	2
6/30/2025	810	651	515	643	2
6/30/2024	338	-1,584	611	614	N/A
3/31/2024	318	-1,478	595	599	N/A
12/31/2023	299	-1,373	579	585	N/A
9/30/2023	473	-1,063	671	678	N/A
6/30/2023	648	-753	763	771	N/A
3/31/2023	977	42	634	640	N/A
12/31/2022	1,306	836	505	510	N/A
9/30/2022	1,522	1,226	529	535	N/A
6/30/2022	1,737	1,616	554	560	N/A
3/31/2022	1,750	1,558	692	705	N/A
12/31/2021	1,763	1,500	830	850	N/A
9/30/2021	1,673	1,319	907	925	N/A
6/30/2021	1,584	1,138	983	999	N/A
3/31/2021	1,450	779	877	884	N/A
12/31/2020	1,317	420	770	768	N/A
9/30/2020	1,403	696	739	741	N/A
6/30/2020	1,489	973	708	714	N/A
3/31/2020	1,550	1,261	652	658	N/A
12/31/2019	1,611	1,549	596	602	N/A
9/30/2019	1,471	1,415	541	547	N/A
6/30/2019	1,331	1,281	486	493	N/A
3/31/2019	1,366	1,370	613	627	N/A
12/31/2018	1,400	1,458	740	760	N/A
9/30/2018	1,389	1,594	668	685	N/A
6/30/2018	1,379	1,729	596	610	N/A
3/31/2018	1,397	1,637	N/A	573	N/A
12/31/2017	1,416	1,545	N/A	536	N/A
9/30/2017	1,396	1,405	N/A	597	N/A
6/30/2017	1,376	1,264	N/A	657	N/A
3/31/2017	1,286	1,221	N/A	592	N/A
12/31/2016	1,197	1,178	N/A	527	N/A
9/30/2016	1,295	1,219	N/A	595	N/A
6/30/2016	1,392	1,260	N/A	664	N/A
3/31/2016	1,400	1,209	N/A	706	N/A
12/31/2015	1,409	1,158	N/A	747	N/A
9/30/2015	1,260	889	N/A	704	N/A
6/30/2015	1,111	619	N/A	661	N/A
3/31/2015	1,049	503	N/A	639	N/A
12/31/2014	987	387	N/A	617	N/A
9/30/2014	873	397	N/A	517	N/A
6/30/2014	758	407	N/A	418	N/A
3/31/2014	716	478	N/A	339	N/A
12/31/2013	674	550	N/A	259	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que DXS sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (2.6%).

Beneficios vs. Mercado: Se prevé que DXS sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: Se espera que DXS sea rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (16.5% al año) de DXS crezcan más rápidamente que los del mercado Australian (5.9% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 16.5% al año) de DXS crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de DXS sea baja dentro de 3 años (6.5%).

Descubre empresas en crecimiento

Análisis de la empresa y estado de los datos financieros

Datos	Última actualización (huso horario UTC)
Análisis de la empresa	2024/12/20 18:38
Precio de las acciones al final del día	2024/12/20 00:00
Beneficios	2024/06/30
Ingresos anuales	2024/06/30

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

Paquete	Datos	Marco temporal	Ejemplo Fuente EE.UU. ^*
Finanzas de la empresa	10 años	Cuenta de resultados Estado de tesorería Balance	Formulario SEC 10-K Formulario SEC 10-Q
Estimaciones del consenso de analistas	+3 años	Previsiones financieras Objetivos de precios de los analistas	Informes de análisis Blue Matrix
Precios de mercado	30 años	Precios de las acciones Dividendos, escisiones y acciones	Datos de mercado ICE Formulario S-1 de la SEC
Propiedad	10 años	Accionistas principales Información privilegiada	Formulario SEC 4 Formulario SEC 13D
Gestión	10 años	Equipo directivo Consejo de Administración	Formulario SEC 10-K Formulario SEC DEF 14A
Principales avances	10 años	Anuncios de empresas	Formulario SEC 8-K

^* ejemplo para los valores estadounidenses, para los no estadounidenses se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Obtenga más información aquí.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en .

Fuentes analistas

DEXUS está cubierta por 22 analistas. 8 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

Analista	Institución
Russell Wright	APP Securities Pty Ltd.
Russell Wright	Barclay Pearce Capital Pty Limited
Benjamin Brayshaw	Barrenjoey Markets Pty Limited

DEXUS Crecimiento futuro

Future controles de criterios 4/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus revenue estimates decrease by 10%

Consensus EPS estimates increase to AU$0.60

Recent updates

Final dividend of AU$0.19 announced

Aware Super Pty Ltd agreed to acquire Office building at 145 Ann Street, Brisbane from DEXUS (ASX:DXS) and Canada Pension Plan Investment Board for approximately AUD 210 million.

An undisclosed buyer acquired B grade suburban office building in Sydney. from DEXUS (ASX:DXS).

Key Executive exercised options to buy AU$413k worth of stock.

Dexus Provides Distribution Policy Update

DEXUS Announces Dividend for the Period Ended June 30, 2024, Payable on August 29, 2024

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

DEXUS to Report First Half, 2025 Results on Feb 19, 2025

Dexus Announces Executive Changes

First half dividend of AU$0.21 announced

High number of new directors

High number of new directors

Upcoming dividend of AU$0.27 per share at 6.7% yield

Dexus Announces the Ordinary Dividend for the Six Month Ending December 31, 2023, Payable on February 29, 2024

Dexus Announces Chief Executive Officer Changes, Effective 28 March 2024

Darren Steinberg to Step Down as Dexus CEO

Darren Steinberg to Step Down as Dexus CEO

Buyers Reportedly on Runway for Airport Stakes

An unknown buyer agreed to acquire A grade office building at 1 Margaret Street from DEXUS (ASX:DXS) for AUD 300 million.

New major risk - Financial position

Full year 2023 earnings: Revenues miss analyst expectations

DEXUS to Report First Half, 2024 Results on Feb 14, 2024

New major risk - Revenue and earnings growth

Consensus revenue estimates decrease by 10%

New major risk - Revenue and earnings growth

An unknown buyer has exchanged contracts to acquire Axxess Corporate Park, Mount Waverley Victoria from DEXUS (ASX:DXS) for approximately AUD 310 million.

An unknown buyer entered into an agreement to acquire CBD A Grade Office Building in Sydney from Dexus (ASX:DXS).

Now 21% undervalued

Board Member recently bought AU$50k worth of stock

First half 2023 earnings released: EPS: AU$0.022 (vs AU$0.75 in 1H 2022)

Dexus Announces Actual Dividend for the Six Month Ending December 31, 2022, Payable on February 28, 2023

Dexus Announces Dividend for the Six Month Ending December 31, 2022, Payable on February 28, 2023

Ashe Morgan Pty Limited acquired Homemaker Prospect from Dexus (ASX:DXS) for AUD 78.9 million.

Ashe Morgan Pty Limited acquired Homemaker Prospect from Dexus (ASX:DXS) for AUD 78.9 million.

Key Executive recently bought AU$77k worth of stock

Dexus Provides Distribution Guidance for the 12 Months Ended 30 June 2023

Sim Lian Group Limited acquired Shepparton Marketplace Shopping Centre from Dexus Wholesale Property Fund, managed by Dexus (ASX:DXS) for $88.1 million.

Key Executive recently bought AU$173k worth of stock

Key Executive exercised options to buy AU$1.4m worth of stock.

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Now 20% undervalued after recent price drop

Dexus to Report Fiscal Year 2023 Results on Aug 16, 2023

Dexus Announces Ordinary Franked Dividend for the Six Months Ended June 30, 2022, Payable on August 30, 2022

Board Member recently bought AU$79k worth of stock

Board Member recently bought AU$225k worth of stock

An Unknown buyer completed the acquisition of 50% of stake in 309-321 Kent Street, Sydney from Dexus (ASX:DXS).

Now 20% undervalued

Dexus (ASX:DXS) agreed to acquire Collimates real estate and domestic infrastructure equity business from Collimate Capital Limited for AUD 550 million.

Dexus Confirms Discussions with AMP

AMP Confirms in Talks to Sell Investment Management Unit with Multiple Parties, Including Dexus

An unknown buyer completed the acquisition of 50% stake in 12 Creek Street, Brisbane from Dexus (ASX:DXS).

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

An unknown buyer entered into agreement to acquire 50% stake in 12 Creek Street, Brisbane from Dexus (ASX:DXS) for AUD 319 million.

An unknown buyer completed the acquisition of 201 Miller Street, North Sydney from DEXUS Office Partnership, managed by Dexus (ASX:DXS).

First half 2022 earnings: EPS and revenues exceed analyst expectations

An unknown buyer agreed to acquire 140 & 150 George Street from DEXUS Office Partnership for approximately AUD 150 million.

Upcoming dividend of AU$0.28 per share

AMP Capital Shopping Centre Fund, managed by AMP Capital Investors Limited acquired a 25% stake in CEV Multimedia ltd from Dexus Wholesale Property Fund managed by Dexus (ASX:DXS) for approximately AUD 420 million.

An unknown buyer exchanged contracts to acquire 201 Miller Street, North Sydney from DEXUS Office Partnership, managed by Dexus (ASX:DXS) AUD 152.4 million.

Shayher Group agreed to acquire Milton Green business park from Dexus Wholesale Property Fund, a fund managed by Dexus (ASX:DXS) and AMP Capital Diversified Property Fund, a fund managed by AMP Capital Investors Limited.

An unknown buyer agreed to acquire A-Grade Office Building Located at 383 Kent Street, Sydney from Dexus (ASX:DXS) for approximately AUD 400 million.

Shareholders May Not Be So Generous With Dexus' (ASX:DXS) CEO Compensation And Here's Why

Chief Financial Officer of Dexus Funds Management Limited Alison Harrop has left the company

Dexus Healthcare Property Fund, a fund managed by Dexus (ASX:DXS), acquired Arcadia Pittwater Private Hospital and Day Rehabilitation Facility from Breckenridge Funds Management for AUD 50.5 million.

Full year 2021 earnings released: FFO AU$0.66 per share (vs AU$0.67 in FY 2020)

Dexus Reportedly to Sell $1.3 Billion of Towers

Consensus EPS estimates increase to AU$0.60

Dexus (ASX:DXS) completed the acquisition of APN Property Group Limited (ASX:APD).

Huge Linkage acquired 60 Miller Street, North Sydney. from Dexus for AUD 273 million.

Dexus Healthcare Property Fund managed by Dexus (ASX:DXS) acquired two inner-city Brisbane medical related properties from Silverstone Developments Pty Ltd for $130.7 million.

Independent Non-Executive Director of DEXUS Funds Management Limited Peter St. George has left the company

Dexus Upgrades Dividend Guidance for the Full Year Ending June 30, 2021